State Street Corporation (STT) 13D/13G Filings for Ultragenyx Pharmaceutical Inc. (RARE)

State Street Corporation 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-12
12:12 pm
Purchase
2026-03-3113GULTRAGENYX PHARMACEUTICAL INC
RARE
STATE STREET CORP
STT
5,021,441
5.100%
5,021,441increase
(New Position)
Filing